Let’s Improve Patient Outcomes Together. Join Us In-Person for Dinner or Virtually – Your Choice!

Saturday, June 3, 2023

The Heterogeneity, Therapeutic Advancements, and Updated Guidelines for the Treatment of RRMM

Sunday, June 4, 2023

Bruton’s Tyrosine Kinase Inhibitors: Updates and Advancements in the Treatment and Management of CLL/SLL

Dinner: 6:30pm - 7:00pm CT
Program: 7:00pm - 8:30pm CT

Marriott Downtown Magnificent Mile
4th Floor - Marriott Ballroom

Commercial support:

The Heterogeneity, Therapeutic Advancements, and Updated Guidelines for the Treatment of RRMM

Supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Bruton’s Tyrosine Kinase Inhibitors: Updates and Advancements in the Treatment and Management of CLL/SLL

Supported by an educational grant from Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.